(5)For the year ended December 31, 2015, interest and other included a gain from the sale of an equity investment. For the year ended December 31, 2014, interest and other included non-cash convertible debt interest expense.
(6)For the years ended December 31, 2015 and December 31, 2014, adjustment to exclude discrete income tax items. Non-GAAP net income and earnings per share include R&D tax credit.
(7)For the year ended December 31, 2014. the calculation of non-GAAP diluted earnings per share gives benefit to the Company's call option on its stock for 34.7 million shares at $5.48. As a result, 5 million shares have been included in non-GAAP diluted shares and net interest expense of $2.0 million has been added back to non-GAAP net income for the non-GAAP diluted earnings per share calculation.
| GAAP to Non-GAAP Reconciliation of First Quarter 2016 guidance: | |||||||||
| GAAP and non-GAAP first quarter revenue guidance: | $410 million to $440 million | ||||||||
| GAAP net income per diluted share | $ | 0.15 | $ | 0.21 | |||||
| Exclude acquired intangible assets amortization | 0.10 | 0.10 | |||||||
| Tax effect of non-GAAP adjustment | (0.02 | ) | (0.02 | ) | |||||
| Non-GAAP net income per diluted share | $ | 0.23 | $ | 0.29 | |||||
